Wellgistics Health, a NASDAQ-listed pharmaceutical distributor, announced a $50 million financing deal on May 08, 2025, integrating XRP as a treasury reserve and payment asset to enhance real-time healthcare transactions, aiming to reduce banking delays and costs across its network.
XRP, developed by Ripple Labs, is a blockchain-based digital asset designed for fast, low-cost cross-border payments, and its adoption by Wellgistics marks a significant step toward institutional use in healthcare, leveraging XRP’s ability to settle transactions in seconds compared to traditional systems.
This move aligns with XRP’s growing institutional adoption, as seen in Ripple’s recent expansions like live XRP-powered remittances between LATAM and Europe, and regulatory licensing in Dubai, reflecting a broader trend of blockchain integration in fintech and healthcare sectors.
